Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
43,000
Employees43,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
43,000
Employees43,000

LLY Key Statistics

Market cap
709.89B
Market cap709.89B
Price-Earnings ratio
81.83
Price-Earnings ratio81.83
Dividend yield
0.67%
Dividend yield0.67%
Average volume
4.94M
Average volume4.94M
High today
$761.28
High today$761.28
Low today
$745.08
Low today$745.08
Open price
$755.00
Open price$755.00
Volume
4.02M
Volume4.02M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$561.65
52 Week low$561.65

LLY News

Investor's Business Daily 20h
Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?

Eli Lilly stock has dropped since Trump announced his plan to appoint Kennedy to the HHS lead role. Is LLY stock a sell? View comments...

Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?
Seeking Alpha 2d
Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed

Him & Hers Health (NYSE:HIMS) closed up ~10% Thursday after a federal court in Texas administratively closed a case in which a compounding drugs industry associ...

Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed
Benzinga 2d
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Eli Lilly and Co. LLY has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over the last month. Chart crea...

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
16.1%
Sell
3.2%

More LLY News

Benzinga 2d
Eli Lilly Board Member Trades $229K In Company Stock - Benzinga

...

Eli Lilly Board Member Trades $229K In Company Stock - Benzinga
Barron's 2d
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

Eli Lilly, Novo Nordisk, and Amgen all look cheap. All of them could experience a massive boost to profits in the years to come. View comments...

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
TipRanks 3d
Eli Lilly and China-based biotech Laekna team on obesity drug

Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its release, announced...

Benzinga 3d
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate

On Wednesday, Verge Genomics announced that Eli Lilly And Co LLY has opted to pursue the development of therapeutics against two validated drug targets for amyo...

Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Seeking Alpha 3d
Eli Lilly in pact with Chinese biotech for novel weight loss therapy

Chinese biotech Laekna Therapeutics on Wednesday announced a clinical collaboration with Eli Lilly (NYSE:LLY) to develop an obesity therapy that can avoid loss...

Eli Lilly in pact with Chinese biotech for novel weight loss therapy
TipRanks 3d
Eli Lilly, Verge announce milestones in ALS collaboration

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for amyotrophic lateral scl...

TipRanks 3d
Laekna Partners with Eli Lilly on Obesity Drug Development

Laekna, Inc. (HK:2105) has released an update. Don't Miss out on Research Tools: Discover the latest stocks recommended by top Wall Street analysts, all in one...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.